Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool

Full metadata record
DC Field Value Language
dc.contributor.authorKim, Ji-Won-
dc.contributor.authorPark, Sunghoon-
dc.contributor.authorJung, Ju-Yang-
dc.contributor.authorKim, Hyoun-Ah-
dc.contributor.authorKwon, Seong-Ryul-
dc.contributor.authorChoi, Sang Tae-
dc.contributor.authorKim, Sung-Soo-
dc.contributor.authorKim, Sang-Hyeon-
dc.contributor.authorSuh, Chang-Hee-
dc.date.accessioned2022-12-02T09:40:08Z-
dc.date.available2022-12-02T09:40:08Z-
dc.date.issued2022-05-
dc.identifier.issn2077-0383-
dc.identifier.issn2077-0383-
dc.identifier.urihttps://scholarworks.bwise.kr/cau/handle/2019.sw.cau/59478-
dc.description.abstractBackground: We investigated the prevalence of and the factors associated with a high risk of osteoporotic fractures in Korean patients with ankylosing spondylitis (AS). Methods: This was a multicenter, retrospective study including 219 AS patients from five university hospitals; the control group was selected by matching age and sex with those of the AS patients. The fracture risk was evaluated based on bone mineral density (BMD) measured by dual-energy X-ray absorptiometry and the fracture risk assessment tool (FRAX) with/without BMD. Results: The mean age of the patients was 47.6 years, and 144 (65.8%) patients were men. According to the WHO criteria and FRAX with/without BMD, the candidates for pharmacological treatment were 44 (20.1%), 20 (13.2%), and 23 (15.1%) patients, respectively, significantly more than those in the healthy control group. Among them, the proportion of patients receiving osteoporosis treatment was 39.1-75%. In logistic regression analysis, menopause was an independent factor for the high risk of fracture according to the WHO criteria and FRAX with/without BMD. C-reactive protein level (odds ratio (OR) 3.8 and OR 6) and glucocorticoid use (OR 1.5 and OR 1.7) were associated with a high risk of osteoporotic fracture based on FRAX without BMD and osteoporosis diagnosed according to the WHO criteria. Conclusions: Our study suggests that both FRAX and WHO criteria may be complementary for treatment decisions to reduce osteoporotic fractures in patients with AS.-
dc.language영어-
dc.language.isoENG-
dc.publisherMDPI-
dc.titlePrevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool-
dc.typeArticle-
dc.identifier.doi10.3390/jcm11102830-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL MEDICINE, v.11, no.10-
dc.description.isOpenAccessY-
dc.identifier.wosid000801560500001-
dc.identifier.scopusid2-s2.0-85130162533-
dc.citation.number10-
dc.citation.titleJOURNAL OF CLINICAL MEDICINE-
dc.citation.volume11-
dc.type.docTypeArticle-
dc.publisher.location스위스-
dc.subject.keywordAuthorankylosing spondylitis-
dc.subject.keywordAuthorosteoporosis-
dc.subject.keywordAuthorosteoporotic fracture-
dc.subject.keywordAuthorbone mineral density-
dc.subject.keywordAuthorfracture risk assessment tool-
dc.subject.keywordPlusAXIAL SPONDYLOARTHRITIS-
dc.subject.keywordPlusDISEASE-ACTIVITY-
dc.subject.keywordPlusWOMEN-
dc.subject.keywordPlusHLA-B27-
dc.subject.keywordPlusHEALTH-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Files in This Item
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE